Investor Relations

SEC Filings

Document Details

Form
Filing Date
Jun 06, 2024
Document Date
Jun 04, 2024
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
BioXcel Therapeutics
Issuer
BioXcel Therapeutics, Inc.